192 related articles for article (PubMed ID: 18387817)
1. Antiangiogenic effects of flavonoids and chalcones.
Mojzis J; Varinska L; Mojzisova G; Kostova I; Mirossay L
Pharmacol Res; 2008 Apr; 57(4):259-65. PubMed ID: 18387817
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
Mirossay L; Varinská L; Mojžiš J
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271940
[TBL] [Abstract][Full Text] [Related]
3. Nutraceuticals as anti-angiogenic agents: hopes and reality.
Dulak J
J Physiol Pharmacol; 2005 Mar; 56 Suppl 1():51-67. PubMed ID: 15800385
[TBL] [Abstract][Full Text] [Related]
4. Soy and breast cancer: focus on angiogenesis.
Varinska L; Gal P; Mojzisova G; Mirossay L; Mojzis J
Int J Mol Sci; 2015 May; 16(5):11728-49. PubMed ID: 26006245
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis as a potential target of pharmaconutrients in cancer therapy.
Granci V; Dupertuis YM; Pichard C
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):417-22. PubMed ID: 20453647
[TBL] [Abstract][Full Text] [Related]
7. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic properties of natural polyphenols from red wine and green tea.
Oak MH; El Bedoui J; Schini-Kerth VB
J Nutr Biochem; 2005 Jan; 16(1):1-8. PubMed ID: 15629234
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic Activity of Flavonoids: A Systematic Review and Meta-Analysis.
Khater M; Greco F; Osborn HMI
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066630
[No Abstract] [Full Text] [Related]
10. Antiangogenic effect of selected phytochemicals.
Varinska L; Mirossay L; Mojzisova G; Mojzis J
Pharmazie; 2010 Jan; 65(1):57-63. PubMed ID: 20187580
[TBL] [Abstract][Full Text] [Related]
11. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
[TBL] [Abstract][Full Text] [Related]
12. [Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it].
Klener P
Klin Onkol; 2010; 23(1):14-20. PubMed ID: 20192069
[TBL] [Abstract][Full Text] [Related]
13. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
van der Meel R; Symons MH; Kudernatsch R; Kok RJ; Schiffelers RM; Storm G; Gallagher WM; Byrne AT
Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic agents in natural products for the treatment of gynecologic disorders.
Aghamohammadi A; Hosseinimehr SJ
Nutr Cancer; 2014; 66(2):206-13. PubMed ID: 24410431
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of resistance to antiangiogenesis therapy.
Azam F; Mehta S; Harris AL
Eur J Cancer; 2010 May; 46(8):1323-32. PubMed ID: 20236818
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic drugs: current knowledge and new approaches to cancer therapy.
Mauriz JL; González-Gallego J
J Pharm Sci; 2008 Oct; 97(10):4129-54. PubMed ID: 18200520
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic cancer therapy.
Cao Y
Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
[TBL] [Abstract][Full Text] [Related]
18. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
19. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
20. Tumor angiogenesis--a potential target in cancer chemoprevention.
Bhat TA; Singh RP
Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
